Back

Dysferlin facilitates the de novo biogenesis of tubular membranes in hypertrophic remodelling

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Pathophysiological mechanisms in cardiomyopathies and hypertrophic remodeling Cardiac Hypertrophy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Ms Nora Josefine Paulke

University Medical Centre of Gottingen (UMG), Goettingen (Germany)

4 More presentations in this session

Presentation thumbnail
Increased Tenascin-C expression contributes to cardiac dysfunction and fibrosis in Duchenne muscular dystrophy
Associate Professor A. Kiss (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
NAV3 is a genetic determinant of myocardial recovery in dilated cardiomyopathy and attenuates cardiac fibrosis
Doctor N. Pereira (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Desmoglein 2 mutant mice reproduce arrhythmogenic right ventricular cardiomyopathy patients' phenotype
Doctor S. Ohno (Suita, JP)
Abstract Slides Video
Presentation thumbnail
The role of the atrium in the development of the Takotsubo Syndrome - investigation of a patient-specific atrial stem cell model
Doctor K. Streckfuss-Boemeke (Wuerzburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiological mechanisms in cardiomyopathies and hypertrophic remodeling

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Locally increased dysferlin expression improves left-ventricular function by stabilizing membrane nanodomains of cardiomyocytes in the myocardial infarction border zone
thumbnail
Congress Presentation
Cellular phenotyping of structural and functional changes in atrial myopathy
thumbnail
Congress Presentation
Titin mediates control of cardiomyocyte proliferation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources